News | June 01, 2015

ECRI Institute Says 3-D Mammography May Provide Deeper, More Detailed Scans

Emerging technology brief details benefits, adoption and coverage of digital breast tomosynthesis

digital breast tomosynthesis, ECRI Institute, technology forecast report

June 1, 2015 — ECRI Institute’s health technology assessment service released an emerging technology brief concerning digital breast tomosynthesis (3-D mammography). The information is based on ECRI’s technology forecast report, "Digital Breast Tomosynthesis for Screening and Diagnosis of Breast Cancer."

Digital breast tomosynthesis is a 3-D breast imaging technique based on full-field digital mammography (FFDM) technology. Unlike conventional mammography units, a tomosynthesis system's X-ray tube sweeps in an arc around the breast to acquire between 50 and 100 two-dimensional (2-D) projections from slightly different angles in about 10 to 20 seconds. The resulting 2-D images are digitally manipulated to create tomograms (i.e., slices) in any plane, thus allowing for 3-D reconstruction that reveals depth. The slices can be displayed individually or in a dynamic "movie" mode.

Providing a 3-D reconstruction of the breast eliminates the problem of overlying tissue that might be mistaken for lesions or that might obscure small cancers, according to technology developers. 

Developers contend that the 3-D images offered by digital breast tomosynthesis might overcome the shortcomings of digital mammography, which produces 2-D images that can mask some small lesions or mistakenly identify dense breast tissue as tumors, potentially missing some cancers or increasing false positives. Some studies suggest that digital breast tomosynthesis may reduce recall rates and increase the number of breast cancers detected compared with digital mammography alone.

Initial diffusion appears to be slow, but its uptake is increasing, with three manufacturers having systems on the market as of April 2015. In recent years, most providers have invested heavily in upgrading to digital mammography, with digital systems representing more than 95 percent of all U.S. mammography units in service as of early 2015.

The U.S. Centers for Medicare and Medicaid Services (CMS) now covers for digital breast tomosynthesis, but several private third-party payers consider the technology investigational and deny coverage. Others consider the technology integral to digital mammography and thus, not separately reimbursable. Without additional reimbursement to recoup acquisition costs, some providers are unlikely to upgrade to digital breast tomosynthesis until they replace their existing digital mammography units.

Some providers appear to be investing in the technology to gain a marketing advantage in competitive markets for women's health services. Manufacturers are also supporting provider marketing efforts with direct-to-consumer campaigns positioning it as being clinically superior to standard digital mammography.

The ECRI Institute is an independent nonprofit organization that conducts research into the most effective approaches for improving patient care.

For more information: www.ecri.org

Related Content

Managing Architectural Distortion on Mammography Based on MR Enhancement
News | Mammography | May 15, 2019
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US)...
Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients
News | MRI Breast | May 09, 2019
When appropriate, short-interval follow-up magnetic resonance imaging (MRI) can be used to identify early-stage breast...
Novel Artificial Intelligence Method Predicts Future Risk of Breast Cancer
News | Artificial Intelligence | May 08, 2019
Researchers from two major institutions have developed a new tool with advanced artificial intelligence (AI) methods to...
Georgia Becomes 38th State With Breast Density Inform Law
News | Breast Density | May 06, 2019
Georgia Gov. Brian Kemp signed breast density inform bill HB62 into law May 3, 2019. The law, which becomes effective...
American Society of Breast Surgeons Issues Risk-based Screening Mammography Guidelines
News | Mammography | May 03, 2019
The American Society of Breast Surgeons (ASBrS) has released the first screening mammography guidelines based on a...
Hologic Launches Trident HD Specimen Radiography System
Technology | Breast Biopsy Systems | April 26, 2019
Hologic Inc. announced global commercial availability of the Trident HD specimen radiography system. The next-...
California Protons Cancer Therapy Center Begins Breast Cancer Study Enrollment
News | Proton Therapy | April 25, 2019
California Protons Cancer Therapy Center announced two major efforts representing significant steps forward in breast...
Women With Coronary Artery Wall Thickness at Risk for Heart Disease
News | Cardiac Imaging | April 25, 2019
The thickness of the coronary artery wall as measured by magnetic resonance imaging (MRI) is an independent marker for...
The Cianna Medical Savi Scout Radar Localization system, showing the console, detector and the marker, with a size comparison and X-ray images inside breast tissue. For more information on the learning curve of its use http://sabcs16.posterview.com/nosl/p/P1-11-06.

The Cianna Medical Savi Scout Radar Localization system, showing the console, detector and the marker, with a size comparison and X-ray images inside breast tissue. For more information on the learning curve of its use http://sabcs16.posterview.com/nosl/p/P1-11-06.

Feature | Breast Imaging | April 24, 2019 | By Greg Freiherr
Wires have traditionally been placed prior to lumpectomy to mark cancerous tissues in the breast.
GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium

GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium in Hollywood, Florida. Photo by Greg Freiherr

Feature | Breast Imaging | April 23, 2019 | By Greg Freiherr
Signs of what the future may look like in women’s health dotted the exhibit floor of the...